In the present report, we provide evidence for the distinct existence of a human natural cytotoxic (HNC) cell. This HNC cell can be identified by the monoclonal antibody HNC-1A3 and by the absence of the T10 antigen, other antigenic markers being shared, at least in part, with natural killer (NK) cells, T cells, or monocytes. In addition, the HNC cell preferentially kills the MA-160 target, the herpes simplex virus-1-infected MA-160 cell line, and the two human tumor cell lines HEp-2 and HF-2. It has weak lytic activity against the NK-sensitive K562 cell line or its relatively NK-resistant clone I subline. The cytotoxic activity of the HNC cell is not augmented by interferon but is markedly enhanced by interleukin 2 and by a measles-virus-induced factor (MVF). Furthermore, it is not inhibited by cyclosporin A (CsA), in contrast to NK cell cytotoxicity against the K562 target cell line which is augmented by interferon, inhibited by CsA, and not affected by MVF. These data suggest that spontaneously cytotoxic cells may belong to more than one subset of human lymphocytes, and that HNC cells may be defined in man using membrane markers, target cell specificity, and sensitivity to biological response modifiers. In the present report, we provide evidence for the distinct existence of a human natural cytotoxic (HNC) cell. This HNC cell can be identified by the monoclonal antibody HNC-1A3 and by the absence of the T10 antigen, other antigenic markers being shared, at least in part, with natural killer (NK) cells, T cells, or monocytes. In addition, the HNC cell preferentially kills the MA-160 target, the herpes simplex virus-i-infected MA-160 cell line, and the two human tumor cell lines HEp-2 and HF-2. It has weak lytic activity against the NK-sensitive K562 cell line or its relatively NK-resistant clone I subline. The cytotoxic activity of the HNC cell is not augmented by interferon but is markedly enhanced by interleukin 2 and by a measles-virusinduced factor (MVF). Furthermore, it is not inhibited by cyclosporin A (CsA), in contrast to NK cell cytotoxicity against the K562 target cell line which is augmented by interferon, inhibited by CsA, and not affected by MVF. These data suggest that spontaneously cytotoxic cells may belong to more than one subset of human lymphocytes, and that HNC cells may be defined in man using membrane markers, target cell specificity, and sensitivity to biological response modifiers.
Introduction
Peripheral blood lymphocytes (PBL) have been shown to spontaneously kill certain tumor target cells (1) as well as virus-infected autologous (2) and allogeneic cells (3) . Human natural killer (NK)' cells that lyse the commonly used NK-sensitive K562 leukemia cell line have been well characterized, and are primarily large granular lymphocytes (4) that express receptors for the Fc portion of IgG (5) and certain cell surface markers (6) (7) (8) . NK cell activity is augmented by interferon (IFN) (9), interleukin 2 (10) , and leukotriene B4 ( 1) . In mice, a second distinct natural cytotoxic effector population has been described: murine natural cytotoxic (NC) cells primarily lyse nonlymphoid Dr. Rola-Pleszczynski is a Scholar of the Fonds de Recherche en Sante du Quebec.
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1. Abbreviations used in this paper: ADCC, antibody-dependent cellular cytotoxicity; CsA, cyclosporin A; E/T, effector/target; FACS, fluorescenceactivated cell sorter; HNC, human natural cytotoxic; HNC-1 A3, mouse monoclonal antibody defining HNC cells; HSV, herpes simplex virus; IFN, interferon; MVF, measles-virus-induced factor; NC, natural cytotoxic; NK, natural killer; PBML, peripheral blood mononuclear leukocytes.
solid tumor cells and differ from NK cells in strain distribution of activity, expression of cell surface antigens, and sensitivity to interferon and interleukins (12, 13) . We have recently produced a mouse monoclonal antibody (HNC-1A3) which defines a subpopulation of human natural cytotoxic cells (14) . In this report, we present new evidence that spontaneous cytotoxic activity in man is also mediated by at least two distinct lymphocyte subsets distinguishable from each other by target cell specificity, cell surface markers, and sensitivity to biological response modifiers.
Methods
Target cells and culture medium. All target cells were cultured and experiments were carried out at 370C in a moisture-laden atmosphere of 5% CO2 in air, using RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% fetal calfserum (Gibco Laboratories) and 100 gg/ml gentamicin. Target cells employed were K562, a human erythroleukemia cell line; MA-160, a human prostatic adenoma cell line, which required anchorage for growth but could be lysed in suspension; HEp-2, the human laryngeal carcinoma cell line (Flow Laboratories Inc., McClean, VA); HF-2, a human melanoma cell line; and the MA-160 cell line persistently infected with herpes simplex virus type 1 (HSV). In some experiments, an NK-resistant subclone (clone I) derived from the K562 cell line was used (15) . Moreover, for antibody-dependent cellular cytotoxicity (ADCC) assays, Raji targets cells were used with rabbit antiRaji IgG.
Effector cells. Peripheral blood mononuclear leukocytes (PBML) were isolated from the blood of normal healthy volunteers by separation on a Ficoll-Hypaque (Pharmacia Fine Chemicals, Inc., Piscataway, NJ) gradient. They consisted of 75-90% lymphocytes and 10-25% monocytes with <1% polymorphonuclears. In specific experiments, PBML subsets were used as described below.
Identification and sorting ofPBML subsets using monoclonal antibodies. The following monoclonal antibodies to human lymphocyte subsets were used: OKT4, OKT8, OKT10 (Ortho Pharmaceutical Corp., Raritan, NJ), Leu-7, Leu-1 1, and fluorescein-conjugated Leu-1 1 (Becton Dickinson, Sunnyvale, CA), and our own antibody HNC-1 A3. For double marker studies, it was biotinylated for use with phycoerythrin-avidin (Becton Dickinson). Fluorescein-conjugated, affinity-purified F(ab')2 goat anti-mouse Ig was purchased from Cappel Laboratories (Cochranville, PA). prepared by the panning method. Antibody-labeled PBML were allowed to adhere to plastic petri dishes precoated with rabbit anti-mouse Ig for 1 h. Nonadherent cells were removed by gently washing the plates, and they contained <5% HNC-IA3+ cells. Adherent cells were removed by vigorously washing the plates, and they contained >90% HNC-1A3+ cells.
Biological response modifiers. Interferon-y (recombinant, Interferon Research), interleukin 2 (chromatography-purified, IFN-and lectin-free) and cyclosporin A (CsA, a generous gift from Dr. G. Holme, Sandoz Inc., East Hanover, NJ), were used as described. Measles-virus-induced factor (MVF) was produced by incubating 5 X I05 PBL with I05 measlesvirus-infected MA-160 cells in a 200-MA volume at 37°C for 4 h as described elsewhere (Girard, M., H. Lieu, and M. Rola-Pleszczynski, manuscript submitted for publication). Briefly, it is a lymphocyte product found in the supernatant of human lymphocytes co-cultured with measles-virus-infected cells, which is dialysable, heat-stable, and not destroyed by trypsin or chymotrypsin. It was shown to augment PBL cytotoxicity against the MA-160 target cell line at a 1/2-1/4 dilution. Cytotoxicity assay. Cytotoxicity was measured by the 51Cr release microassay; 5 X 103 target cells were used in each microtiter well with various numbers of effector lymphocytes, as indicated, so as to measure lysis on the linear portion of an effector:target (E/T) ratio curve. After a 5-h incubation period, 100 ul of supernatant was collected and cytotoxicity estimated from the released 5tCr by counting in a gamma-counter (Nuclear-Chicago Corp., Des Plaines, IL). Percentage-specific "tCr release was calculated using the following formula: 
Results
Membrane markers ofNC cells. Since our original description (14) of a monoclonal antibody, HNC-1A3, which defines human natural cytotoxic effector cells, these lymphocytes have been further studied using other monoclonal antibodies (Table I) . HNC-1A3+ cells were found to be negative for OKT10, Leu-7, and anti-HLA-DR, while '60% of them were labeled with Leu-11, a monoclonal antibody recognizing the Fc receptor. Their Fc receptor for IgG was also shown to be functional (Table  II) : HNC-1A3+ cells were able to bind IgG-coated ox erythrocytes Cold cell competition. Use of unlabeled cold cells in competition assays allowed us to identify two other cell lines, in addition to the MA-160 cell line, which would compete with each other but not with the NK cell target K562 line (Fig. 1) . Both the HEp-2 and the HF-2 cell lines inhibited killing of MA-160 targets while neither inhibited K562 killing, suggesting that different recognition structures or different effector cells were involved in the killing of K562 target on the one hand and MA-160, HEp-2, or HF-2 targets on the other.
Target cell specificity ofHNC-1A3+ cells. In order to further define the effector cells involved in these two kinds of cytotoxic activity, monocyte-depleted HNC-1A3-labeled PBL were either sorted using the FACS (Fig. 2) or panned on petri dishes previously coated with rabbit anti-mouse Ig (Fig. 3) . The HNC-1A3+ population was found to exert significantly less killing of K562 targets than unsorted PBML, whereas it was much more active than PBML in killing MA-160 targets, at all E/T cell ratios tested (Fig. 2) . Moreover, the HNC-1A3-(or nonadherent) fraction was the main effector cell population in cytotoxicity directed at either the K562 cell line or clone I, a relatively resistant subclone of K562 (Fig. 3) .
Sensitivity to biological response modifiers. In addition to membrane markers and target cell specificity, human natural cytotoxic (HNC) cells can be distinguished from classical NK cells by sensitivities to drugs and lymphokines. When PBML were preincubated with recombinant interferon-y for 1 h before the cytotoxicity assay, a significant augmentation of NK killing of K562 targets was observed as expected (Fig. 4) . However, no significant change in MA-160 killing occurred, while cytotoxicity against HSV moderately but significantly decreased with interferon-y pretreatment. In contrast, interleukin 2 was effective in enhancing both HNC and NK cell activities against their respective target cells (Table III) .
CsA dependent manner (Fig. 5) . In contrast, no such inhibition was observed with HSV or MA-160 targets. On the other hand, MVF, which has a rapid and rather selective effect in augmenting HNC cytotoxicity against the MA-160 targets, produced no significant effect in HSV or K562 cytotoxicity assays (Fig. 6) (14) which defines a subset of human natural cytotoxic lymphocytes that preferentially kill anchorage-dependent target cells rather than the K562 cell line. These findings suggested that HNC-I A3' cells may represent the human equivalent of murine NC cells (13) , which are distinguishable from mouse NK cells in terms of cell surface markers, strain distribution, target cell specificity, and sensitivity to IFN or interleukins.
In analogy to murine NC cells, HNC cells represent a distinct lymphocyte subset. They express the HNC-1A3 antigen but not (<2%) the HNK-1 (Leu-7) antigen characteristic of human NK cells (14) . In further contrast to NK cells, HNC cells do not express the T10 (OKT10) antigen. On the other hand, some cell surface marker studies further suggest that these recognition sites are located on mostly nonoverlapping subpopulations. A third set of characteristics distinguishing HNC and NK cells concerns their sensitivity to biological response modifiers. NK cell-mediated cytotoxicity has been shown to be augmented by IFN (9) and NK cells themselves can produce IFN. When cytotoxicity against uninfected MA-160 cells was assayed in the presence ofpure IFN, no significant change in cytotoxic activity of PBL was observed at conditions associated with enhanced killing of K562 targets. HSV-I -infected MA-160 cells were actually killed less in the presence of IFN than in its absence. Conversely, 5-h supernatants of measles-virus-pulsed T cells significantly enhanced HNC killing ofMA-160 targets, but were without effect on cytotoxicity of PBML against K562 targets. On the other hand, CsA has been shown to inhibit the generation of cytotoxic T and NK cells (19) , and to reversibly inhibit NK cell activity (20) . HNC cells not only were uninhibited by CsA, but their cytotoxicity could still be augmented by measles-virusinduced T cell supernatants in the presence of CsA. The mechanisms underlying this striking and unexpected effect of MVF and CsA are unknown at the present time. NK and NC cells share several properties, in both mouse and man: i.e., preexistence without induction in the normal host, lack of H-2 or HLA restriction, and ability to lyse several tumor or virus-infected cell types. Other properties distinguish human and murine NC cells from NK cells, as illustrated in this report. Presently available data do not permit us, however, to answer the question of whether NC and NK cells derive from separate cell lineages or represent two variants or two activation or differentiation stages of a unique effector cell type.
The potential importance ofdefining the HNC subpopulation of human cytotoxic effector cells is twofold. Firstly, it may help explain and clarify some discrepancies that are being observed during NK cell studies, be they related to target cell specificity or responses to various immunomodulating factors (e.g., lack of response to IFN). Secondly, the availability of separate markers for HNC and NK cells, in terms of cell surface antigens and sensitivity to biological response modifiers, should allow for further exploration of the spontaneous cytotoxic activity of human PBL by permitting selective inhibition, activation, and sorting of HNC and NK effector cells. Such approaches may facilitate a greater intuition into the fine mechanisms controlling host defenses against viruses and tumors.
